Mackay Shields LLC Vertex Pharmaceuticals Inc Transaction History

Mackay Shields LLC

$499 Million
Q4 2024

18 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 03, 2022	SELL	$234.96 - $292.55 $8.6 Million - $10.7 Million	-36,585 Closed	0 $0
Q1 2022 May 13, 2022	SELL	$221.42 - $260.97 $309,545 - $364,836	-1,398 Reduced 3.68%	36,585 $9.55 Million
Q4 2021 Feb 04, 2022	SELL	$177.01 - $223.45 $282,153 - $356,179	-1,594 Reduced 4.03%	37,983 $8.34 Million
Q3 2021 Nov 12, 2021	SELL	$181.39 - $202.99 $207,872 - $232,626	-1,146 Reduced 2.81%	39,577 $7.18 Million
Q2 2021 Aug 13, 2021	SELL	$187.49 - $221.1 $1.82 Million - $2.15 Million	-9,706 Reduced 19.25%	40,723 $8.21 Million
Q1 2021 May 14, 2021	SELL	$207.02 - $241.31 $1.7 Million - $1.98 Million	-8,195 Reduced 13.98%	50,429 $10.8 Million
Q4 2020 Feb 16, 2021	SELL	$207.01 - $276.09 $7.09 Million - $9.45 Million	-34,235 Reduced 36.87%	58,624 $13.9 Million
Q3 2020 Nov 04, 2020	BUY	$255.65 - $303.1 $12.3 Million - $14.5 Million	47,931 Added 106.68%	92,859 $25.3 Million
Q2 2020 Jul 31, 2020	SELL	$225.48 - $295.8 $7.59 Million - $9.96 Million	-33,669 Reduced 42.84%	44,928 $13 Million
Q1 2020 May 08, 2020	BUY	$199.77 - $247.81 $6.96 Million - $8.63 Million	34,837 Added 79.61%	78,597 $18.7 Million
Q4 2019 Feb 11, 2020	SELL	$166.71 - $223.91 $630,997 - $847,499	-3,785 Reduced 7.96%	43,760 $9.58 Million
Q3 2019 Nov 01, 2019	BUY	$166.23 - $187.09 $489,381 - $550,792	2,944 Added 6.6%	47,545 $8.06 Million
Q2 2019 Aug 13, 2019	BUY	$164.61 - $190.37 $55,638 - $64,345	338 Added 0.76%	44,601 $8.18 Million
Q1 2019 May 13, 2019	BUY	$163.73 - $194.7 $911,648 - $1.08 Million	5,568 Added 14.39%	44,263 $8.14 Million
Q4 2018 Feb 14, 2019	SELL	$151.91 - $192.21 $313,997 - $397,298	-2,067 Reduced 5.07%	38,695 $6.41 Million
Q3 2018 Nov 14, 2018	SELL	$167.73 - $192.74 $80,510 - $92,515	-480 Reduced 1.16%	40,762 $7.86 Million
Q2 2018 Aug 06, 2018	SELL	$145.72 - $169.96 $193,224 - $225,366	-1,326 Reduced 3.12%	41,242 $7.01 Million
Q1 2018 May 03, 2018	BUY	$151.6 - $177.13 $6.45 Million - $7.54 Million	42,568 New	42,568 $6.94 Million

Others Institutions Holding VRTX

# of Institutions

1,757

Shares Held

228M

Call Options Held

1.63M

Put Options Held

1.47M

Capital World Investors Los Angeles, CA

28.3M
Shares

$13.8 Billion
1.8% of portfolio
Vanguard Group Inc Valley Forge, PA

23.3M
Shares

$11.3 Billion
0.17% of portfolio
Black Rock Inc. New York, NY

21.3M
Shares

$10.4 Billion
0.23% of portfolio
State Street Corp Boston, MA

12M
Shares

$5.82 Billion
0.2% of portfolio
Capital Research Global Investors Los Angeles, CA

10.4M
Shares

$5.07 Billion
0.9% of portfolio

View Full List

About VERTEX PHARMACEUTICALS INC

Ticker VRTX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 256,691,008
Market Cap $125B
Description
Vertex Pharmaceuticals Incorporated, a biotechnology company, engages in developing and commercializing therapies for treating cystic fibrosis. The company markets SYMDEKO/SYMKEVI, ORKAMBI, and KALYDECO to treat patients with cystic fibrosis who have specific mutations in their cystic fibrosis transmembrane conductance regulator gene; and TRIKAF...

More about VRTX

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Mackay Shields LLC, based on Form 13F filings with the SEC.

News

Stay updated on Mackay Shields LLC with notifications on news.

Account